Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN92382106
ISRCTN92382106
Completed
未知

The effectiveness of an integrated cardioprotective dietary intervention compared with an average UK diet in reducing cardiovascular disease risk factors in older men and women aged 40 - 70 years

King's College London (KCL) (UK)0 sites196 target enrollmentOctober 11, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
King's College London (KCL) (UK)
Enrollment
196
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 11, 2010
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
King's College London (KCL) (UK)

Eligibility Criteria

Inclusion Criteria

  • •Healthy men and women, aged 40 \- 70 years

Exclusion Criteria

  • •1\. A reported history of angina, myocardial infarction, peripheral vascular disease, congenital heart disease or stroke
  • •2\. Asymptomatic atrial fibrillation
  • •3\. Type 1 or type 2 diabetes mellitus (fasting plasma glucose greater than 7 mmol/L)
  • •4\. Seated blood pressure greater than 160/105 mmHg
  • •5\. Current use of medication for lowering blood cholesterol (statins) or blood pressure
  • •6\. Body mass index less than 18\.5 and greater than 35 kg/m2
  • •7\. An overall risk of cardiovascular disease over the next ten years of greater than 20% assessed according to current NICE guidelines in combination with untreated high blood pressure or raised cholesterol
  • •8\. Clinical history of cancer (excluding basal cell carcinoma) in the past five years
  • •9\. Chronic renal, liver or inflammatory bowel disease
  • •10\. Current cigarette smoker (confirmed by urinary cotinine analysis)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Evaluation of Cardioprotective Nutrition in people with Metabolic Syndrome and High Blood Pressure: a randomized clinical trial
RBR-9v9r6vjniversidade do Estado da Bahia - UNEB
Recruiting
Phase 3
Evaluation of the effects of the cardioprotective diet on prevention of the incidence of cardiotoxicitycardiotoxicity in patients with breast cancer receiving Anthracycline.Malignant NeoplasmsC00-C97
IRCT20131218015860N7School of Traditional Medicine, Traditional Medicine and Materia Medica Research Center,Shahid Behes60
Completed
Not Applicable
Comparative analysis of two solutions for miocardial protection in the correction of congenital cardiopathies.Children with acyanogenic congenital heart defects operated for total correctionTraced problems - Myocardial damageSpecific descriptors - Interventricular communication, Atrioventricular communication, Right ventricle with double outlet, Tetralogy of Fallot, Myocardial protection.Q21.0Q21.2Q20.1Q21.3C14.280H02.403.670C14.280.647C14.280.671
RBR-9wqbx9Hospital do Coração de Messejana Dr. Carlos Alberto Studart Gomes
Not yet recruiting
Not Applicable
A clinical trial to study the cardioprotective effect of remote ischemic preconditioning in acute coronary syndrome patientsHealth Condition 1: I228- Subsequent ST elevation (STEMI) myocardial infarction of other sites
CTRI/2023/10/058663Department of Health Research
Active, not recruiting
Phase 1
Evaluation of the protective effect on the heart of a betablocker drug, nebivolol, in patients with breast cancer or diffuse B-cell lymphoma for which anthracyclinic chemotherapy has been plannedTo prevent cardiotoxicity of chemotherapeutic agents (anthracyclines)MedDRA version: 20.1Level: PTClassification code 10008444Term: Chemotherapy cardiotoxicity attenuationSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2017-004618-24-ITIRCCS ISTITUTO CLINICO HUMANITAS80